Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy
Authors
Keywords
-
Journal
LEUKEMIA
Volume 27, Issue 4, Pages 914-924
Publisher
Springer Nature
Online
2012-11-29
DOI
10.1038/leu.2012.348
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40
- (2012) Y. Yang et al. BLOOD
- Retrospective multicenter study on the development of peripheral lymphocytosis following second-line dasatinib therapy for chronic myeloid leukemia
- (2011) Su Jin Lee et al. AMERICAN JOURNAL OF HEMATOLOGY
- Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC/MS-MS
- (2011) Stéphane Bouchet et al. CLINICA CHIMICA ACTA
- Stabilin-1/CLEVER-1, a type 2 macrophage marker, is an adhesion and scavenging molecule on human placental macrophages
- (2011) Senthil Palani et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Evolving treatment strategies for patients newly diagnosed with chronic myeloid leukemia: the role of second-generation BCR–ABL inhibitors as first-line therapy
- (2011) P J Shami et al. LEUKEMIA
- Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation
- (2011) A Kreutzman et al. LEUKEMIA
- Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results
- (2011) P D le Coutre et al. LEUKEMIA
- A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors
- (2011) John J. Powers et al. LEUKEMIA & LYMPHOMA
- Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
- (2011) Theonie Anastassiadis et al. NATURE BIOTECHNOLOGY
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
- (2011) Vinod P Balachandran et al. NATURE MEDICINE
- Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?
- (2011) Jan K Hennigs et al. BMC Pulmonary Medicine
- Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy
- (2010) A. Kreutzman et al. BLOOD
- Latent Cytomegalovirus infection amplifies CD8 T-lymphocyte mobilisation and egress in response to exercise
- (2010) James E. Turner et al. BRAIN BEHAVIOR AND IMMUNITY
- Immunoprofiling of patients with chronic myeloid leukemia at diagnosis and during tyrosine kinase inhibitor therapy
- (2010) Peter Rohon et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The BCR/ABL-inhibitors imatinib, nilotinib and dasatinib differentially affect NK cell reactivity
- (2010) Julia Salih et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion
- (2010) Yasunobu Nagata et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Lck is a key target of imatinib and dasatinib in T-cell activation
- (2010) K C Lee et al. LEUKEMIA
- Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia
- (2010) D Bixby et al. LEUKEMIA
- Prevalence of large granular lymphocytosis in patients with chronic myelogenous leukemia (CML) treated with dasatinib
- (2010) Jason N. Valent et al. LEUKEMIA RESEARCH
- Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
- (2010) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
- (2010) Giuseppe Saglio et al. NEW ENGLAND JOURNAL OF MEDICINE
- Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme
- (2010) Kristian Ovaska et al. Genome Medicine
- Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion
- (2009) Kimmo Porkka et al. CANCER
- A novel dasatinib-sensitive RCSD1-ABL1 fusion transcript in chemotherapy-refractory adult pre-B lymphoblastic leukemia with t(1;9)(q24;q34)
- (2009) S. Mustjoki et al. HAEMATOLOGICA
- Selective Mobilization of Cytotoxic Leukocytes by Epinephrine
- (2009) Stoyan Dimitrov et al. JOURNAL OF IMMUNOLOGY
- Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
- (2009) F J Giles et al. LEUKEMIA
- Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy
- (2009) S Mustjoki et al. LEUKEMIA
- Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia
- (2008) K. Porkka et al. BLOOD
- The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro
- (2008) Stephen Blake et al. CLINICAL IMMUNOLOGY
- Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia
- (2008) D. H. Kim et al. HAEMATOLOGICA
- Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib
- (2008) A Hochhaus et al. LEUKEMIA
- Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase
- (2008) J Cortes et al. LEUKEMIA
- EphA and ephrin-A proteins regulate integrin-mediated T lymphocyte interactions
- (2007) Nigel Sharfe et al. MOLECULAR IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now